Medical Condition News

RSS

Penn researchers lay groundwork for developing lncRNA-based tools for new cancer treatment

Growing insights about a significant, yet poorly understood, part of the genome - the "dark matter of DNA" -- have fundamentally changed the way scientists approach the study of diseases.

13 Oct 2015

Team-based delivery models can improve quality of care in patients with cardiovascular disease

Patients with coronary artery disease, heart failure, and atrial fibrillation receive comparable outpatient care from physicians and advanced practice providers-- physician assistants and nurse practitioners - although all clinicians fell short in meeting performance measures, according to a study published today in the Journal of the American College of Cardiology.

13 Oct 2015

Study explains why anemia is a common side effect of anti-cancer drugs

Many types of leukemia are caused by loss of enzymes such as Pten, which normally keeps cell growth in check, or conversely, the over-activation of enzymes that normally enhance cell proliferation, such as Shp2.

13 Oct 2015

Computer-based cognitive training improves attention, memory in childhood cancer survivors

Intensive, adaptive computer-based cognitive training presented as a video game helped improve working memory and other cognitive skills of childhood cancer survivors and holds hope for revolutionizing management of the late effects of cancer treatment.

13 Oct 2015

Loyola University successfully performs double-lung transplant in patient with debilitating lung disease

Before he developed a debilitating lung disease, outdoorsman Michael Olson had taken 57 canoe and fishing trips to Canada.

13 Oct 2015

ATA announces first-year research grants to support promising young researchers

The American Thyroid Association (ATA) is pleased to announce the awarding of first-year grants to support two young researchers selected from among a pool of applicants who proposed projects that will contribute novel insights and information with the potential to lead to new drug targets and therapeutic strategies to improve the treatment of thyroid cancer and patient outcomes.

13 Oct 2015

Small heat shock protein as model for Alzheimer’s medication

In Alzheimer’s disease proteins clump together to long fibrils causing the death of nerve cells. Small heat shock proteins can counteract this effect. Scientists, therefore, hope to deploy them as agents in the treatment of neurodegenerative diseases. Using the example of a small heat shock protein, researchers at the Technical University of Munich (TUM) and the Helmholtz Zentrum München have now uncovered how the protein interacts with other proteins.

13 Oct 2015

Scientists create 3D image of key protein involved in blood and other cancer development

Scientists at the Walter and Eliza Hall Institute have created the first three-dimensional image of a key protein known to be involved in the development of blood and other cancers.

13 Oct 2015

IU investigators find how cancer-induced bone destruction triggers skeletal muscle weakness

Cancer researchers at Indiana University and their colleagues have discovered how cancer-induced bone destruction causes skeletal muscle weakness.

12 Oct 2015

Cranberry juice consumption may protect against cardiovascular disease

Results from a new study presented at the Cranberry Health Research Conference preceding the annual Berry Health Benefits Symposium 2015 in Madison, WI, revealed that cranberry juice consumption may play a role in protecting against cardiovascular disease.

12 Oct 2015

Study shows that IVIG could prevent brain atrophy, delay onset of Alzheimer's disease

In a Sutter Institute of Medical Research study published this month in the Journal of Neurology, Neurosurgery, and Psychiatry, the blood product intravenous immunoglobulin, or IVIG, was found to reduce brain atrophy and cognitive decline in patients in the early, pre-dementia phase of Alzheimer's disease.

12 Oct 2015

Study identifies four distinct types of bowel cancer

Bowel cancer can be divided up into four distinct diseases, each with its own set of biological characteristics, a major new study reports.

12 Oct 2015

Is dyspraxia a battle of the sexes?

New findings released Monday 12 October 2015 have revealed a significant gap in the diagnosis – and therefore, treatment – of dyspraxia, otherwise known as developmental co-ordination disorder (DCD), amongst young women and girls.

12 Oct 2015

New clinical study focuses on investigational treatment to reduce impact of key protein from the brain

The Nantz National Alzheimer Center at Houston Methodist Hospital is part of a landmark clinical trial that looks at removing a key protein from the brain to prevent memory loss at least a decade before symptoms are noticed in healthy older adults.

12 Oct 2015

Researchers explore how nitrate-rich beet juice may affect high altitude acclimatization

Ever since human beings first began climbing the world's tallest mountains, they have struggled with a basic problem: altitude sickness, caused by lower air pressures which affect the ability of our bodies to take up oxygen.

12 Oct 2015

Astute Medical, Fosun Long-March sign distribution agreement for NephroCheck Test on the Astute140 Meter

Astute Medical, Inc. today announced the signing of an agreement with Shanghai Fosun Long March Medicine Science Co. Ltd., a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co. Ltd., for distribution of Astute's NephroCheck Test on the Astute140 Meter in China. In addition to its planned launch of the NephroCheck Test in China, FOSUNPHARMA invested $20 million in Astute.

12 Oct 2015

Can-Fite's CF102 granted Orphan Drug Designation by EMA for treatment of hepatocellular carcinoma

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.

12 Oct 2015

Sequenom signs clinical collaboration with University Medical Center Hamburg-Eppendorf

Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it has entered into a clinical collaboration with University Medical Center Hamburg-Eppendorf (UKE) in Germany.

12 Oct 2015

Researchers find protein that plays crucial role in development of allergic airway inflammation

Allergies are becoming more commonplace, particularly in industrialised coun-tries. In addition to hay fever, allergic asthma is currently considered to be one of the most widespread allergies. UFZ researchers and their colleagues from the University of Leipzig have recently been successful in finding a protein that plays a critical role in the development of allergic airway inflammation.

12 Oct 2015

Exposure to acrylamide through STP use much smaller than exposure from diet or cigarette smoking

The first comprehensive assessment of the acrylamide content of smokeless tobacco products (STPs) has shown that exposure to acrylamide through STP use is much smaller than --approximately 1% of -- exposure from the diet or from cigarette smoking.

12 Oct 2015

Medical Condition News

Penn researchers lay groundwork for developing lncRNA-based tools for new cancer treatment

Team-based delivery models can improve quality of care in patients with cardiovascular disease

Study explains why anemia is a common side effect of anti-cancer drugs

Computer-based cognitive training improves attention, memory in childhood cancer survivors

Loyola University successfully performs double-lung transplant in patient with debilitating lung disease

ATA announces first-year research grants to support promising young researchers

Small heat shock protein as model for Alzheimer’s medication

Scientists create 3D image of key protein involved in blood and other cancer development

IU investigators find how cancer-induced bone destruction triggers skeletal muscle weakness

Cranberry juice consumption may protect against cardiovascular disease

Study shows that IVIG could prevent brain atrophy, delay onset of Alzheimer's disease

Study identifies four distinct types of bowel cancer

Is dyspraxia a battle of the sexes?

New clinical study focuses on investigational treatment to reduce impact of key protein from the brain

Researchers explore how nitrate-rich beet juice may affect high altitude acclimatization

Astute Medical, Fosun Long-March sign distribution agreement for NephroCheck Test on the Astute140 Meter

Can-Fite's CF102 granted Orphan Drug Designation by EMA for treatment of hepatocellular carcinoma

Sequenom signs clinical collaboration with University Medical Center Hamburg-Eppendorf

Researchers find protein that plays crucial role in development of allergic airway inflammation

Exposure to acrylamide through STP use much smaller than exposure from diet or cigarette smoking

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News